These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 10208830)

  • 1. Cytoprotective effect of ulinastatin, a Kunitz-type protease inhibitor, on hypoxic injury in L2 cells treated with antimycin A via stabilization of lysosomal fragility.
    Nakahama H; Kuribayashi K; Sugita M; Shinkawa T
    Pulm Pharmacol Ther; 1999; 12(1):1-6. PubMed ID: 10208830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoprotective effect of ulinastatin on LLC-PK1 cells treated with antimycin A, gentamicin, and cisplatin.
    Ishibashi M; Yamasaki F; Nakakuki M; Shinkawa T; Mizota M
    Nephron; 1997; 76(3):300-6. PubMed ID: 9226230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats.
    Nakakuki M; Yamasaki F; Shinkawa T; Kudo M; Watanabe M; Mizota M
    Can J Physiol Pharmacol; 1996 Jan; 74(1):104-11. PubMed ID: 8963945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective action of ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility.
    Yamasaki F; Ishibashi M; Nakakuki M; Watanabe M; Shinkawa T; Mizota M
    Nephron; 1996; 74(1):158-67. PubMed ID: 8883035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoprotective effects of ulinastatin against hypoxic injury to LLC-PK1 cells.
    Nakahama H; Nakanishi T; Sugita M
    Nephron; 1994; 68(3):411-2. PubMed ID: 7838283
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of O-linked carbohydrate of human urinary trypsin inhibitor on its lysosomal membrane-stabilizing property.
    Kato Y; Kudo M; Shinkawa T; Mochizuki H; Isaji M; Shiromizu I; Hoshida K
    Biochem Biophys Res Commun; 1998 Feb; 243(2):377-83. PubMed ID: 9480817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (4). Effects of tobramycin alone and in combination with latamoxef on the stability of rat kidney lysosomal membranes.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1987 Jan; 43(1):73-80. PubMed ID: 3573418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinases in renal cell death.
    Yang X; Schnellmann RG
    J Toxicol Environ Health; 1996 Jul; 48(4):319-32. PubMed ID: 8691504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulinastatin is a novel protease inhibitor and neutral protease activator.
    Umeadi C; Kandeel F; Al-Abdullah IH
    Transplant Proc; 2008 Mar; 40(2):387-9. PubMed ID: 18374077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis.
    Ma T; Kang C; Shao H; Qi Q; Hu W
    Eur Surg Res; 2006; 38(5):445-50. PubMed ID: 16912483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ulinastatin on CFU-C colony formation in mouse myelocyte cultures.
    Endo S; Inada K; Kasai T; Koike S; Kamei Y; Yamada Y; Wakabayashi G; Yoshida M; Yanagiya Y
    Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):109-12. PubMed ID: 9055354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulinastatin alone does not reduce caspase 3-mediated apoptosis in protease-positive Aeromonas hydrophilia-induced sepsis.
    Su BH; Chiu HY; Soga T; Lin KJ; Hsu CT
    J Formos Med Assoc; 2007 Feb; 106(2):97-104. PubMed ID: 17339152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in the plasma concentration of reduced glutathione observed in rats with liver damage induced by lipopolysaccharide/D-galactosamine: effects of ulinastatin, a urinary trypsin inhibitor.
    Okabe H; Irita K; Kurosawa K; Tagawa K; Koga A; Yamakawa M; Yoshitake J; Takahashi S
    Circ Shock; 1993 Dec; 41(4):268-72. PubMed ID: 8143354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ulinastatin in experimental acute arterial occlusion in rats.
    Nishimura K; Kumada K; Okamoto R; Ban T
    Eur J Surg; 1991 Feb; 157(2):115-6. PubMed ID: 1676303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of ulinastatin on the release of granulocyte elastase during pancreas surgery].
    Mizushima M; Ueda M; Murakami F; Hanaoka Y; Yamamura T; Kemmotsu O
    Masui; 1990 Aug; 39(8):1028-32. PubMed ID: 2232129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ulinastatin on microcirculation under hemodilution and hypothermia].
    Komori M
    Masui; 1990 Jun; 39(6):741-50. PubMed ID: 2388393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ulinastatin on cutaneous microcirculation during inhalation of 100% oxygen in a rabbit ear chamber.
    Shiotani M; Takada K; Komori M; Nakata T; Taguchi A; Suzuki H
    In Vivo; 1997; 11(2):173-7. PubMed ID: 9179612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulinastatin, a protease inhibitor, attenuates intestinal ischemia/reperfusion injury.
    Li XK; Suzuki H; Kimura T; Kawabe A; Uno T; Harada Y
    Transplant Proc; 1994 Aug; 26(4):2423-5. PubMed ID: 8066795
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of apocynin on antimycin A-induced cell damage in osteoblastic MC3T3-E1 cells.
    Choi EM; Lee YS
    J Appl Toxicol; 2012 Sep; 32(9):714-21. PubMed ID: 21538410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ulinastatin on delayed neuronal death in the gerbil hippocampus].
    Abe H; Sugino N; Matsuda T; Kanamaru T; Oyanagi S; Mori H
    Masui; 1996 Jan; 45(1):38-43. PubMed ID: 8865723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.